Lv5
960 积分 2021-07-11 加入
Postoperative Adjuvant Therapy Benefits Non‐pCR Patients Rather Than pCR Patients for Locally Advanced ESCC: A Multicenter Real‐World Study
4天前
已完结
Adjuvant Therapies for Esophageal Cancer
4天前
已完结
胃癌肝转移诊断与综合治疗中国专家共识
5天前
已完结
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non–Small Cell Lung Cancer
9天前
已完结
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
11天前
已完结
IMUN-03 IT-IO: INTRATHECAL ADMINISTRATION OF NIVOLUMAB AND IPILIMUMAB IN COMBINATION WITH SYSTEMIC COMBINATION OF NIVOLUMAB AND IPILIMUMAB IN PATIENTS WITH NSCLC OR MELANOMA AND NEWLY DIAGNOSED LEPTOMENINGEAL METASTASIS, A MULTICENTRIC PHASE I STUDY - PRELIMINARY DATA
11天前
已完结
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer
17天前
已完结
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer
17天前
已完结
First-line treatment for advanced NSCLC in older patients and those with poor performance status
24天前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
24天前
已完结
皖公网安备34019202002308
